Supplementary Table S3 from Early infiltration of innate immune cells to the liver depletes HNF4a and promotes extra-hepatic carcinogenesis

Goldman, Omer; Adler, Lital N.; Hajaj, Emma; Croese, Tommaso; Darzi, Naama; Galai, Sivan; Tishler, Hila; Ariav, Yarden; Lavie, Dor; Fellus-Alyagor, Liat; Oren, Roni; Kuznetsov, Yuri; David, Eyal; Jaschek, Rami; Stossel, Chani; Singer, Oded; Malitsky, Sergey; Barak, Renana; Seger, Rony; Erez, Neta; Amit, Ido; Tanay, Amos; Saada, Ann; Golan, Talia; Rubinek, Tamar; Sang Lee, Joo; Ben-Shachar, Shay; Wolf, Ido; Erez, Ayelet

doi:10.1158/2159-8290.27025313.v1

- No file added yet -

Supplementary Table S3 from Early infiltration of innate immune cells to the liver depletes HNF4a and promotes extra-hepatic carcinogenesis

journal contribution

posted on 2024-09-16, 09:31 authored by Omer Goldman, Lital N. Adler, Emma Hajaj, Tommaso Croese, Naama Darzi, Sivan Galai, Hila Tishler, Yarden Ariav, Dor Lavie, Liat Fellus-Alyagor, Roni Oren, Yuri Kuznetsov, Eyal David, Rami Jaschek, Chani Stossel, Oded Singer, Sergey Malitsky, Renana Barak, Rony Seger, Neta Erez, Ido Amit, Amos Tanay, Ann Saada, Talia Golan, Tamar Rubinek, Joo Sang Lee, Shay Ben-Shachar, Ido Wolf, Ayelet Erez

Supplementary Table S3 lists the primers used for qPCR

History

ARTICLE ABSTRACT

Multiple studies identified metabolic changes within the tumor and its microenvironment during carcinogenesis. Yet, the mechanisms by which tumors affect the host metabolism are unclear. We find that systemic inflammation induced by the cancer leads to liver infiltration of myeloid cells at early extrahepatic carcinogenesis. The infiltrating immune cells via IL-6-pSTAT3 immune-hepatocyte crosstalk cause the depletion of a master metabolic regulator, HNF4a, consequently leading to systemic metabolic changes that promote breast and pancreatic cancer proliferation and a worse outcome. Preserving HNF4 levels maintains liver metabolism and restricts carcinogenesis. Standard liver biochemical tests can identify early metabolic changes and predict patients' outcomes and weight loss. Thus, the tumor induces early metabolic changes in its macro-environment with diagnostic and potentially therapeutic implications for the host.